Press Releases
Introducing SMi’s5th conference on Drug Safety 2018 this June
Drug Safety 2018 aims to discuss the latest findings and current thinking on pharmacovigilance. Importantly, it will address the newest regulatory updates and interpretations...
News
Hear From AstraZeneca at SMi’s HPAPI 2018
SMi are delighted to present the 2nd annual Highly Potent Active Pharmaceutical Ingredients (HPAPI) conference being held at Holiday Inn, Kensington Forum, London, on...
Press Releases
Discover Novel Based Vial Based Technology, Presented by Roche this May
Building on the success of SMi's 10th Annual Flagship Conference Pre-Filled Syringes, SMi are thrilled to present the launch of their Injectable Drug Delivery...
News
The Pistoia Alliance Calls for Greater Life Sciences Collaboration to Build the ‘Lab of the Future’
The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, is calling upon the...
News
Pricing system reform and generics trend apparent at CPhI Japan 2018
Increased international generic API companies and suppliers are reported at next month’s CPhI Japan 2018, traditionally an innovative drug focussed market, due to recent...
News
Ian Rentsch is Clinerion’s new CEO
Clinerion’s Board of Directors announces the appointment of Ian Rentsch as new CEO of the company, effective April 1, 2018. Clinerion,...
Press Releases
Sarepta Therapeutics gazes FDA approval of Golodirsen (SRP-4053) in Patients with Duchenne Muscular Dystrophy (DMD) Amenable to Skipping Exon 53
Sarepta Therapeutics, Inc , a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare neuromuscular diseases. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read